Initial studies demonstrate that Retatrutide – a dual stimulator of gut hormone and glucose-dependent insulinotropic polypeptide receptors – presents a substantial breakthrough in weight management therapies. Unlike existing treatments , this dual-action compound seems to influence hunger and calorie utilization by means of multiple pathways .